Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Getting new auth cookie, if you see this message a lot, tell someone!
  • Getting new auth cookie, if you see this message a lot, tell someone!
Review

Tickborne diseases other than Lyme in the United States

Christa Eickhoff, MD and Jason Blaylock, MD, FACP
Cleveland Clinic Journal of Medicine July 2017, 84 (7) 555-567; DOI: https://doi.org/10.3949/ccjm.84a.16110
Christa Eickhoff
Infectious Diseases Fellow, National Capitol Consortium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
Jason Blaylock
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIGURE 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1

    Geographic distribution of nationally notifiable tickborne diseases, 2015.

Tables

  • Figures
    • View popup
    TABLE 1

    Rocky Mountain spotted fever

    Pathogen: Rickettsia rickettsii
    Tick vectors: Dermacentor variabilis, Dermacentor andersoni, Rhipicephalus sanguineus
    Geographic distribution: Widespread; most common in south-central and south-Atlantic regions
    Classic presentation: Fever, headache, rash, weakness, malaise, myalgia, thrombocytopenia, anemia, hyponatremia, increased aminotransferase levels
    Diagnosis: Serologic antibody testing with a 4-fold increase between acute and convalescent serology with a minimum peak titer ≥ 1:64; polymerase chain reaction assay with low sensitivity; immunohistochemistry and cell culture rarely used
    Treatment: Doxycycline, typically for 7 days (range 5–10 days)
    • View popup
    TABLE 2

    Rickettsia parkeri infection

    Tick vector: Amblyomma maculatum
    Geographic distribution: Eastern and southern regions
    Classic presentation: Inoculation eschar, fever, headache, myalgia, rash, thrombocytopenia, leukopenia, increased aminotransferase levels
    Diagnosis: Same as for Rocky Mountain spotted fever
    Treatment: Same as for Rocky Mountain spotted fever
    • View popup
    TABLE 3

    Rickettsia species 364D infection

    Tick vector: Dermacentor occidentalis
    Geographic distribution: Northern California, Pacific coast
    Classic presentation: Inoculation eschar, fever, headache, myalgia
    Diagnosis: Same as for Rocky Mountain spotted fever
    Treatment: Same as for Rocky Mountain spotted fever
    • View popup
    TABLE 4

    Human granulocytic anaplasmosis

    Pathogen: Anaplasma phagocytophilum
    Tick vectors: Ixodes scapularis, Ixodes pacificus
    Geographic distribution: Northeast and upper Midwest, northern Pacific coast
    Classic presentation: Fever, headache, myalgia, malaise, cough, opportunistic infections in severe cases, thrombocytopenia, leukopenia, lymphopenia, elevated aminotransferase levels; laboratory abnormalities may no longer be present after 1 week of symptoms
    Diagnosis: Polymerase chain reaction assay available; 4-fold increase between acute and convalescent serology with a minimum peak titer ≥ 1:64; morulae in granulocytes on Giemsa- or Wright- stained peripheral smear; cell culture rarely used
    Treatment: Doxycycline, typically for 10 days (range 7–14 days)
    • View popup
    TABLE 5

    Human monocytic ehrlichiosis

    Pathogen: Ehrlichia chaffeensis
    Tick vectors: Primarily Amblyomma americanum
    Geographic distribution: Southeastern, south-central, and mid-Atlantic regions
    Classic presentation: Fever, headache, myalgia, malaise, cough, gastrointestinal symptoms, rash, meningitis, thrombocytopenia, leukopenia, lymphopenia, anemia, hyponatremia, elevated aminotransferase levels; laboratory abnormalities may no longer be present after 1 week of symptoms
    Diagnosis: Polymerase chain reaction assay available; 4-fold increase between acute and convalescent serology with a minimum peak titer ≥ 1:64; morulae in monocytes on Giemsa- or Wright-stained peripheral smear; cell culture rarely used
    Treatment: Doxycycline, typically for 7–14 days
    • View popup
    TABLE 6

    Human Ewingii ehrlichiosis

    Pathogen: Ehrlichia ewingii
    Tick vector: Primarily Amblyomma americanum
    Geographic distribution: Southeastern and south-central regions
    Classic presentation: Similar to human granulocytic anaplasmosis and human monocytic erhlichiosis; laboratory abnormalities may no longer be present after 1 week of symptoms
    Diagnosis: Polymerase chain reaction assay
    Treatment: Doxycycline, typically for 7–14 days
    • View popup
    TABLE 7

    Ehrlichia muris-like agent infection

    Tick vector: Ixodes scapularis (most likely)
    Geographic distribution: Limited to Wisconsin and Minnesota
    Classic presentation: Similar to human granulocytic anaplasmosis and human monocytic erhlichiosis; laboratory abnormalities may no longer be present after 1 week of symptoms
    Diagnosis: Polymerase chain reaction assay
    Treatment: Doxycycline, typically for 7–14 days
    • View popup
    TABLE 8

    Babesiosis

    Pathogen: Babesia microti (most likely)
    Tick vector: Ixodes scapularis
    Geographic distribution: Northeastern region and upper-midwestern states
    Classic presentation: Fever, fatigue, malaise, headache, myalgia, arthralgia, nausea, anorexia, cough, hemolytic anemia, thrombocytopenia, leukopenia, elevated aminotransferase levels
    Diagnosis: Babesia microti intraerythrocytic ring form (trophozoites) or merozoites in tetrads (Maltese cross) identified on Giemsa- or Wright-stained peripheral smear; polymerase chain reaction assay; serology
    Treatment: Atovaquone with azithromycin for mild to moderate disease and clindamycin with quinine for severe disease; consider exchange transfusion in severe disease; typical treatment course is 7-10 days and at least 6 weeks in highly immunocompromised patients
    • View popup
    TABLE 9

    Tickborne relapsing fever

    Pathogen: Borrelia hermsii
    Tick vectors: Ornithodoros hermsi; less commonly Ornithodoros parkeri and Ornithodoros turicata
    Geographic distribution: Pacific coast, north-western and southwestern regions
    Classic presentation: Relapsing fever, headache, myalgia, arthralgia, gastrointestinal symptoms
    Diagnosis: Detection of spirochetes on peripheral smear with either Wright or Giemsa stain or darkfield microscopy; fourfold increase between acute and convalescent serology with a minimum peak titer ≥ 1:64; polymerase chain reaction assay in research settings.
    Treatment: Tetracycline for 10 days (based on expert opinion)
    • View popup
    TABLE 10

    Borrelia miyamotoi infection

    Tick vectors: Ixodes scapularis, Ixodes pacificus
    Geographic distribution: Northeastern, north- central, and far western regions
    Classic presentation: Fever, headache, myalgia, arthralgia, gastrointestinal symptoms, meningoencephalitis, thrombocytopenia, elevated aminotransferase levels
    Diagnosis: No validated test available, though culture, polymerase chain reaction, and serology are performed in research settings
    Treatment: Doxycycline for 2–4 weeks (based on expert opinion)
    • View popup
    TABLE 11

    Southern tick-associated rash illness

    Pathogen:Unknown
    Tick vector: Amblyomma americanum
    Geographic distribution: Southeastern, southcentral, mid-Atlantic, and midwestern regions
    Classic presentation: Fever, headache, fatigue, myalgia, erythema migrans rash (similar to Lyme disease)
    Diagnosis: No diagnostic tests are available since the pathogen is unknown; diagnosis based on symptoms, geographic location, and possibility of a tick bite; a known tick bite by A americanum is helpful in distinguishing from Lyme disease.
    Treatment: Doxycycline is often given, though it is unknown whether antibiotics are necessary or beneficial
    • View popup
    TABLE 12

    Tularemia

    Pathogen: Francisella tularensis
    Tick vectors: Amblyomma americanum, Dermacentor variabilis, Dermacentor andersoni
    Geographic distribution: South-central region
    Classic presentation:
    Ulceroglandular: Red painful papule at the site of tick exposure that evolves into a black eschar; fever, headache, myalgia, malaise, lymphadenopathy
    Glandular: Same as ulceroglandular except primary lesion not recognized
    Diagnosis: 4-fold increase between the acute and convalescent sera or a single titer ≥ 1:160; culture may also be performed
    Treatment: Streptomycin or gentamicin for at least 10 days; for less severe disease, ciprofloxacin or doxycycline for 14 days
    • View popup
    TABLE 13

    Powassan virus infection

    Tick vectors: Lineage I: Ixodes cookei; lineage II (also known as deer tick virus): Ixodes scapularis
    Geographic distribution: Great Lakes and northeastern regions
    Classic presentation: Fever, confusion, seizures, focal neurologic deficits, rash, gastrointestinal symptoms
    Diagnosis: Cerebrospinal fluid testing for virus- specific IgM and neutralizing antibodies; serum antibody testing; nucleic acid amplification; immunohistochemistry on autopsy tissue and viral culture are options
    Treatment: Supportive care
    • View popup
    TABLE 14

    Heartland virus infection

    Tick vector: Amblyomma americanum (most likely)
    Geographic distribution: Limited to Missouri and Tennessee
    Classic presentation: Fever, fatigue, headache, myalgia, gastrointestinal symptoms, leukopenia, thrombocytopenia
    Diagnosis: No diagnostic tests are currently available; rule out ehrlichioses
    Treatment: Supportive care
PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 84 (7)
Cleveland Clinic Journal of Medicine
Vol. 84, Issue 7
1 Jul 2017
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Tickborne diseases other than Lyme in the United States
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
Please verify that you are a real person.
Citation Tools
Tickborne diseases other than Lyme in the United States
Christa Eickhoff, Jason Blaylock
Cleveland Clinic Journal of Medicine Jul 2017, 84 (7) 555-567; DOI: 10.3949/ccjm.84a.16110

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Tickborne diseases other than Lyme in the United States
Christa Eickhoff, Jason Blaylock
Cleveland Clinic Journal of Medicine Jul 2017, 84 (7) 555-567; DOI: 10.3949/ccjm.84a.16110
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget

Jump to section

  • Article
    • ABSTRACT
    • ROCKY MOUNTAIN SPOTTED FEVER
    • OTHER SPOTTED FEVER GROUP RICKETTSIAL INFECTIONS
    • EHRLICHIOSES: EHRLICHIOSIS AND ANAPLASMOSIS
    • BABESIOSIS
    • TICKBORNE RELAPSING FEVER
    • BORRELIA MIYAMOTOI INFECTION
    • SOUTHERN TICK-ASSOCIATED RASH ILLNESS
    • TULAREMIA
    • TICKBORNE VIRAL INFECTIONS
    • COINFECTION
    • PREVENTION
    • TAKE-HOME POINTS
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • Appropriate diagnosis of tickborne infections
  • PubMed
  • Google Scholar

Cited By...

  • Evaluation of a Novel Multiplex High-Definition PCR Assay for Detection of Tick-Borne Pathogens in Whole-Blood Specimens
  • Google Scholar

More in this TOC Section

  • High-output heart failure from arteriovenous dialysis access: A structured approach to diagnosis and management
  • Direct oral anticoagulants: Challenging prescribing scenarios in everyday practice
  • IgA nephropathy: Update on pathogenesis and treatment
Show more Review

Similar Articles

Subjects

  • Dermatology
  • Emergency Medicine
  • Infectious Diseases

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire